Get started
Author

Jamie L. Scism-Bacon

Observed names: J L Scism, J Scism-Bacon, J. L. Scism-Bacon, J. L. Scism‐Bacon, Jamie L Scism, Jamie L. Scism, Jamie Scism-Bacon, Jamie Scism-bacon, Jamie Scism‐Bacon, Scism-Bacon, J. L., Scism-Bacon, Jamie
OpenAlex ID: A5026051510
Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia
2006 · E. Wright, J. L. Scism-Bacon, et al. · International Journal of Clinical Practice · 517
PDF
Advancing Insulin Therapy in Type 2 Diabetes Previously Treated With Glargine Plus Oral Agents
2007 · Julio Rosenstock, Andrew J. Ahmann, et al. · Diabetes Care · 191
PDF
DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week Results
2009 · John B. Buse, Bruce H.R. Wolffenbuttel, et al. · Diabetes Care · 126
High-dose Insulin Therapy: is it Time for U-500 Insulin?
2009 · Wendy S. Lane, Elaine K. Cochran, et al. · Endocrine Practice · 124
Safety and Efficacy of Once-Weekly Exenatide Compared With Insulin Glargine Titrated to Target in Patients With Type 2 Diabetes Over 84 Weeks
2012 · Michaela Diamant, Luc Van Gaal, et al. · Diabetes Care · 96
PDF
A comparison of intensive mixture therapy with basal insulin therapy in insulin‐naïve patients with type 2 diabetes receiving oral antidiabetes agents
2006 · S. J. Jacober, J. L. Scism‐Bacon, et al. · Diabetes Obesity and Metabolism · 64
Probenecid-inhibitable efflux transport of valproic acid in the brain parenchymal cells of rabbits: a microdialysis study
2000 · Jamie L Scism, Karen M Powers, et al. · Brain Research · 47
Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: A noninferiority intensification substudy of the DURABLE trial
2010 · William F. Miser, Richard Arakaki, et al. · Clinical Therapeutics · 46
Effect of Growth Hormone Replacement on BMD in Adult-Onset Growth Hormone Deficiency
2007 · Peter J Snyder, Beverly MK Biller, et al. · Journal of Bone and Mineral Research · 45
Evaluation of an in vitro coculture model for the blood-brain barrier: Comparison of human umbilical vein endothelial cells (ECV304) and rat glioma cells (C6) from two commercial sources
1999 · Jamie L. Scism, Dennis A. Laska, et al. · In Vitro Cellular & Developmental Biology - Animal · 29
Impact of Race/Ethnicity on the Efficacy and Safety of Commonly used Insulin Regimens: A Post HOC Analysis of Clinical Trials in Type 2 Diabetes Mellitus
2010 · Jaime A. Davidson, Lyndon B. Lacaya, et al. · Endocrine Practice · 28
Evaluation of the Role of P-Glycoprotein in Ivermectin Uptake by Primary Cultures of Bovine Brain Microvessel Endothelial Cells
1998 · Jayna M. Rose, Sara L. Peckham, et al. · Neurochemical Research · 28
Effects of probenecid on brain-cerebrospinal fluid-blood distribution kinetics of E-Delta 2-valproic acid in rabbits.
1997 · J L Scism, K M Powers, et al. · PubMed · 15
Safety of exenatide once weekly for 52 weeks in J apanese patients with type 2 diabetes mellitus
2012 · Yukiko Onishi, Hiroyuki Koshiyama, et al. · Journal of Diabetes Investigation · 14
PDF
DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week Results: Safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes
2020 · Shemonsky, N. K., Herman, W. H., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill) · 6
Efficacy and Safety of Dulaglutide Versus Placebo and Exenatide in Type 2 Diabetes (AWARD-1)
2013 · Carol Wysham, Thomas Blevins, et al. · Canadian Journal of Diabetes · 6
Exenatide bid observational study (ExOS): baseline population characteristics of a prospective research study to evaluate the clinical effectiveness of exenatide bid use in patients with type 2 diabetes in a real-world setting
2011 · Richard M. Bergenstal, Louis P. Garrison, et al. · Current Medical Research and Opinion · 4
The Risk of Severe Hypoglycemia in Patients with Type 2 Diabetes Mellitus Starting Insulin Therapy with Premixed Insulin Analogues Taken Twice Daily: An Observational Study in Turkish Patients
2013 · Adem Yürümez, Mustafa Sait Gönen, et al. · Endocrinology research and practice. · 2
1.2 Efficacy and Safety of Dulaglutide versus Placebo and Exenatide in Type 2 Diabetes (AWARD-1) (66-OR)
2013 · Carol H. Wysham, Thomas C. Blevins, et al. · Nederlands Tijdschrift voor Diabetologie · 1
Nächste Stufe der Insulintherapie bei Typ-2-Diabetes nach Vortherapie mit Glargin und oralen Antidiabetika: Lispro-Mischinsulin prandial vs. Glargin/Lispro als Basal/Bolus
2008 · O Bachmann, C Kazda, et al. · Diabetologie und Stoffwechsel
Works count: 22
Citation count: 1,389
H-index: 14
I10-index: 14
Year
Topic
Type